ADVANCE-ID Network

The ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID) Network is a global network for infectious disease clinical studies. Our aim is to conduct rapid, cost-effective randomised controlled trials to deliver relevant and high quality evidence to guide clinical practice. We hope to achieve this vision through equity (shared ownership), sustainability (build long-term capacity and trust) and engagement of key stakeholders (including clinicians, scientists, governments, industry).